While waiting for the Final clinical trial report to be published, not much sales activities is expected to achieve.
However, if I bring your attention to the item 9.2 of the current and previous 4C:
Estimates Product manufacturing and operating costs for Q3 was $44,000 and Q4 is $637,000. With actual manufacturing and operating costs for Q3 at $82,000.
This has given us a precursor that the management is planning a ramp up in production in the next quarter.
Why?
I think the answer is very obvious.
Ann: Quarterly Report and Appendix 4C, page-3
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
